Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
NEUP · NASDAQ · Pharmaceutical Preparations
$2.35+0.03 (+1.29%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Neuphoria Therapeutics (NEUP) · oqro.io/stocks/NEUP · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
5%+ stake · Stake as of Sep 30, 2026 · Filed Oct 5, 2026
AdvisorShares Trust now owns 5.8% of NEUP as a passive investorSourceInsider trade · Traded Oct 21, 2025 · Filed Oct 24, 2025
10% owner purchased ~$3.28M of NEUP shares in the open marketSource